Compound sodium sulfate tablets and preparation method and application thereof
By adding polyethylene glycol and sodium dodecyl sulfate to the intestinal preparation drugs, the fluidity and fragility of sodium sulfate tablets are improved, and the amount of drugs used, many side effects and disintegration speed of existing intestinal preparation drugs is solved. The problem of slowness achieves safe and efficient intestinal cleaning effect and stability.
Patent Information
- Application Number
- CN202310418792.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-04-19
- Publication Date
- 2024-12-03
- Estimated Expiration
- 2043-04-19
AI Technical Summary
The existing intestinal preparation drugs have problems such as large doses, many side effects, slow disintegration speed, and poor coating effect. It is difficult to provide an ideal intestinal cleaning that is safe and effective, low-volume, and does not produce clinically significant changes in body fluids or electrolytes. drug.
Compound sodium sulfate tablets are used, and a certain mass ratio of polyethylene glycol and sodium dodecyl sulfate are added to improve the fluidity and fragility of the material, and the disintegration rate is increased through specific preparation methods, including sodium sulfate and sulfuric acid. A combination of a sheet core composed of magnesium, potassium chloride, polyethylene glycol and sodium dodecyl sulfate and a coating layer.
It achieves the efficient cleaning effect of intestinal cleaning drugs, reduces adverse reactions, reduces water demand, improves product stability and patient acceptance, and avoids the risk of acute renal injury caused by phosphate drugs.
Smart Images

Figure BDA0004185948950000071 
Figure BDA0004185948950000082 
Figure BDA0004185948950000091
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of pharmaceutical preparations, and in particular relates to a compound sodium sulfate tablet and a preparation method and application thereof. Background Art
[0002] Bowel preparation is an important preoperative preparation for electronic colonoscopy or capsule endoscopy and other intestinal examinations or treatments, or various open surgeries. Its effectiveness directly affects the quality of the examination or operation. At the same time, safe, effective and comfortable bowel preparation methods can reduce patients' pain, be easily accepted by patients, and improve patients' compliance with examinations and treatments.
[0003] Intestinal preparation methods include restricted diet, enema, and oral medication. Restricted diet alone cannot achieve the purpose of intestinal preparation, but is only a basic auxiliary method commonly used in various examinations and surgeries. Conventional 1-2 days of light, low-fat diet with little residue, liquid diet the night before, and fasting on the morning of the day. Enema is cumbersome to operate and has certain damage to the direct intestine. It is generally used in combination with oral medication. Oral medication is convenient to take and easy to accept. Oral hypertonic dehydration agent 20% mannitol, which will produce a large amount of gas during fermentation in the intestinal cavity, and gastrointestinal irritation is obvious. The main component of polyethylene glycol electrolyte solution is non-absorbable isotonic polyethylene glycol, which is currently a more commonly used intestinal preparation drug, but it also has the disadvantages of large effective dose (4L each time), poor taste, and many side effects, which increases the pain of intestinal preparation for patients. Mannitol is a hypertonic dehydration drug. Mannitol produces flammable gases such as methane under the action of intestinal bacteria. During high-frequency electrosurgery, it may cause the risk of gas explosion. Therefore, this method is generally not used in endoscopic treatment. Sodium phosphate is a highly osmotic bowel cleanser. There have been reports of severe hyperphosphatemia and death after oral sodium phosphate solution, complicated by oliguric renal failure. The US FDA has issued a warning, saying that reports have found that oral phosphate drugs for bowel cleansing before colonoscopy or other similar examinations may be related to acute phosphate nephropathy in patients.
[0004] CN110339158A discloses a sodium sulfate potassium magnesium oral solution and a preparation method thereof, wherein the oral solution is made up of sodium sulfate, potassium sulfate, magnesium sulfate, sodium benzoate, sucralose, pullulan, malic acid, citric acid, 0.05-0.15 g of strawberry flavor and purified water. However, as an oral solution, the dosage is large and the side effects are significant.
[0005] CN104257686A discloses a pharmaceutical composition of compound sodium sulfate, potassium sulfate and magnesium sulfate, and a preparation method and use thereof. The composition is composed of sodium sulfate decahydrate, potassium sulfate, magnesium sulfate heptahydrate, sodium benzoate, sucralose, an acidulant, powder flavor and water. An oral liquid is obtained by encapsulation. As a new oral liquid drug combination for intestinal preparation, although it solves a part of the clinical electrolyte problems of oral liquid drugs for intestinal preparation, it has a large dosage, a bad taste, and even the side effects caused by sodium sulfate cannot be solved.
[0006] The original patent US11033498B2 discloses a method for cleaning the colon, the method comprising: A) administering a first dose of a colon cleansing composition, the composition being essentially an oral dosage form, the dosage form comprising about 17.75 grams of sodium sulfate, about 2.7 grams of magnesium sulfate, and about 2.25 grams of potassium chloride. The original product produced according to this method has poor friability, has the problem of edge knocking during the coating process, and the coating effect is not ideal. In addition, the tablets prepared by this method have a very slow disintegration rate and a slow dissolution rate.
[0007] Therefore, there is a clinical need for an ideal intestinal cleansing drug that is safe, effective, easy to use, low in volume, and does not produce clinically significant changes in body fluids or electrolytes. Summary of the invention
[0008] The technical problem to be solved by the present invention is the above-mentioned defects in the prior art. A compound sodium sulfate tablet is provided, in which polyethylene glycol and sodium dodecyl sulfate are added in a certain mass ratio, which can not only improve the fluidity and friability of the material, but also unexpectedly solve the problem of slow disintegration speed. The present invention also provides a preparation method thereof.
[0009] The compound sodium sulfate tablet of the present invention consists of a tablet core and a coating layer; the tablet core comprises the following components: sodium sulfate, magnesium sulfate, potassium chloride, polyethylene glycol and sodium lauryl sulfate.
[0010] Further preferably, the core comprises the following components in parts by weight:
[0011] Sodium sulfate 147.9 parts;
[0012] 22.5 parts of magnesium sulfate;
[0013] 18.8 parts of potassium chloride.
[0014] Preferably, the mass ratio of polyethylene glycol and sodium lauryl sulfate to the tablet core is 4.5% to 10.7%, and the mass ratio of polyethylene glycol to sodium lauryl sulfate is 3.5:1.
[0015] Preferably, the coating layer is one or more of hydroxypropyl methylcellulose, hydroxypropyl cellulose, povidone, polyvinyl alcohol, acrylic resin, polyvinyl acetal diethylamino acetate, propylene glycol, glycerol, polyethylene glycol, and polyethylene glycol polyvinyl alcohol graft copolymer.
[0016] Preferably, the mass content of the coating layer is 2-5% of the compound sodium sulfate tablet.
[0017] The preparation method of the compound sodium sulfate tablet comprises the following steps:
[0018] (1) sieving sodium sulfate, magnesium sulfate and potassium chloride;
[0019] (2) mixing the sieved sodium sulfate, magnesium sulfate, potassium chloride and polyethylene glycol to obtain a mixture I;
[0020] (3) mixing the mixture I with sodium lauryl sulfate to obtain a mixture II;
[0021] (4) Compressing the mixture II into tablets and coating the tablets to obtain compound sodium sulfate tablets.
[0022] Preferably, the mesh size of the sieve in step (1) is 0.5 mm to 2.5 mm.
[0023] Preferably, the mixing time of step (2) is 5 min to 40 min; and the mixing time of step (3) is 5 min to 20 min.
[0024] The compound sodium sulfate tablet is an intestinal cleansing medicine.
[0025] Specifically, the preparation method of the compound sodium sulfate tablets comprises the following steps:
[0026] (1) Sodium sulfate, magnesium sulfate and potassium chloride are sieved, and the sieve mesh size is 0.5 mm to 2.5 mm.
[0027] (2) Mix the sieved sodium sulfate, magnesium sulfate, potassium chloride and polyethylene glycol for 5 to 40 minutes to obtain mixture I.
[0028] (3) Mixing mixture I with sodium dodecyl sulfate for 5 min to 20 min to obtain mixture II.
[0029] (4) Compressing the mixture II into tablets and coating the tablets to obtain compound sodium sulfate tablets.
[0030] The sulfate in the compound sodium sulfate tablet formula provided by the present invention can provide sulfate ions, which are not easily absorbed. The osmotic effect of unabsorbed sulfate anions and other related cations allows water to be retained in the gastrointestinal tract. When a large amount of water is ingested, watery diarrhea will occur, thereby achieving the effect of cleansing the colon.
[0031] The magnesium ions, potassium ions and sodium ions in the formula of the compound sodium sulfate tablet provided by the present invention can avoid electrolyte disorder caused by large-scale secretion of intestinal fluid.
[0032] The compound sodium sulfate tablet provided by the present invention contains no phosphate at all, and there is no risk of acute kidney injury caused by phosphate-based colon cleansing drugs.
[0033] Compared with the prior art, the present invention has the following beneficial effects:
[0034] (1) The preparation method of the compound sodium sulfate tablet of the present invention adopts a mass ratio of polyethylene glycol to sodium lauryl sulfate of 3.5:1, which accelerates the disintegration of the tablet, improves the hardness and friability of the tablet, and improves the quality and stability of the product.
[0035] (2) Compared with the currently available colon cleansing drugs, the compound sodium sulfate tablets prepared by the present invention have the advantages of good cleansing effect, milder adverse reactions, and less water required for taking.
[0036] (3) The compound sodium sulfate tablets prepared by the present invention are convenient and quick to take when used as intestinal cleansing drugs, and are easily accepted by patients. Oral solid tablets do not have the bad taste problem of liquid preparations, and patient compliance is better.
[0037] (4) The preparation method of the compound sodium sulfate tablet of the present invention has simple production process, good production continuity, high degree of mechanization, and is suitable for industrial production. DETAILED DESCRIPTION
[0038] The embodiments of the present invention will be described in detail below in conjunction with the examples, but those skilled in the art will appreciate that the following examples are only used to illustrate the present invention and should not be considered to limit the scope of the present invention. If the specific conditions are not specified in the examples, they are carried out according to conventional conditions or conditions recommended by the manufacturer. If the manufacturer is not specified for the reagents or instruments used, they are all conventional products that can be purchased commercially. The coating process described is an existing coating process and is not discussed in detail.
[0039] Example 1
[0040] The compound sodium sulfate oral tablets, prescription (100 tablets), are composed of a tablet core and a coating layer;
[0041] The core tablets include the following components:
[0042] Sodium sulfate 147.9 g;
[0043] Magnesium sulfate 22.5g;
[0044] Potassium chloride 18.8 g;
[0045] Polyethylene glycol 7g;
[0046] Sodium dodecyl sulfate 2g.
[0047] The coating layer includes the following components:
[0048] Hydroxypropyl methylcellulose 4g;
[0049] Polyethylene glycol 2g.
[0050] The preparation method of the compound sodium sulfate tablet comprises the following steps:
[0051] (1) Sodium sulfate, magnesium sulfate and potassium chloride are sieved, and the sieve mesh size is 1.5 mm.
[0052] (2) Mix the sieved sodium sulfate, magnesium sulfate, potassium chloride and polyethylene glycol for 20 minutes to obtain mixture I. (3) Mix mixture I with sodium dodecyl sulfate for 8 minutes to obtain mixture II.
[0053] (4) Compressing the mixture II into tablets and coating the tablets to obtain compound sodium sulfate tablets.
[0054] Example 2
[0055] The compound sodium sulfate oral tablets, prescription (100 tablets), are composed of a tablet core and a coating layer;
[0056] The core tablets include the following components:
[0057] Sodium sulfate 147.9 g;
[0058] Magnesium sulfate 22.5g;
[0059] Potassium chloride 18.8 g;
[0060] Polyethylene glycol 17.5 g;
[0061] Sodium lauryl sulfate 5g.
[0062] The coating layer includes the following components:
[0063] Polyethylene glycol polyvinyl alcohol graft copolymer 7g;
[0064] Polyethylene glycol 4g.
[0065] The preparation method of the compound sodium sulfate tablet comprises the following steps:
[0066] (1) Sodium sulfate, magnesium sulfate and potassium chloride are sieved, and the sieve mesh size is 2.5 mm.
[0067] (2) Mix the sieved sodium sulfate, magnesium sulfate, potassium chloride and polyethylene glycol for 40 minutes to obtain mixture I. (3) Mix mixture I with sodium dodecyl sulfate for 20 minutes to obtain mixture II.
[0068] (4) Compressing the mixture II into tablets and coating the tablets to obtain compound sodium sulfate tablets.
[0069] Example 3
[0070] The compound sodium sulfate oral tablets, prescription (100 tablets), are composed of a tablet core and a coating layer;
[0071] The core tablets include the following components:
[0072] Sodium sulfate 147.9 g;
[0073] Magnesium sulfate 22.5g;
[0074] Potassium chloride 18.8 g;
[0075] Polyethylene glycol 10.5 g;
[0076] Sodium lauryl sulfate 3g.
[0077] The coating layer includes the following components:
[0078] 4.2g of polyethylene glycol polyvinyl alcohol graft copolymer.
[0079] The preparation method of the compound sodium sulfate tablet comprises the following steps:
[0080] (1) Sodium sulfate, magnesium sulfate and potassium chloride are sieved, and the sieve mesh size is 0.5 mm.
[0081] (2) Mix the sieved sodium sulfate, magnesium sulfate, potassium chloride and polyethylene glycol for 5 minutes to obtain mixture I. (3) Mix mixture I with sodium dodecyl sulfate for 20 minutes to obtain mixture II.
[0082] (4) Compressing the mixture II into tablets and coating the tablets to obtain compound sodium sulfate tablets.
[0083] Example 4
[0084] The compound sodium sulfate oral tablets, prescription (100 tablets), are composed of a tablet core and a coating layer;
[0085] The core tablets include the following components:
[0086] Sodium sulfate 147.9 g;
[0087] Magnesium sulfate 22.5g;
[0088] Potassium chloride 18.8 g;
[0089] Polyethylene glycol 10.5 g;
[0090] Sodium lauryl sulfate 3g.
[0091] The coating layer includes the following components:
[0092] Polyvinyl alcohol 2g;
[0093] Hydroxypropyl methylcellulose 2.4 g;
[0094] Polyethylene glycol 3g.
[0095] The preparation method of the compound sodium sulfate tablet comprises the following steps:
[0096] (1) Sodium sulfate, magnesium sulfate and potassium chloride are sieved, and the sieve mesh size is 1.5 mm.
[0097] (2) Mix the sieved sodium sulfate, magnesium sulfate, potassium chloride and polyethylene glycol for 25 minutes to obtain mixture I. (3) Mix mixture I with sodium dodecyl sulfate for 5 minutes to obtain mixture II.
[0098] (4) Compressing the mixture II into tablets and coating the tablets to obtain compound sodium sulfate tablets.
[0099] Comparative Example 1
[0100] The compound sodium sulfate oral tablets, the prescription (dosage for 100 tablets) is as follows:
[0101] Chip:
[0102] Sodium sulfate 147.9 g;
[0103] Magnesium sulfate 22.5g;
[0104] Potassium chloride 18.8 g;
[0105] Polyethylene glycol 5g;
[0106] Sodium dodecyl sulfate 2g.
[0107] The preparation method thereof is specifically as follows:
[0108] (1) Sodium sulfate, magnesium sulfate and potassium chloride are sieved with a sieve mesh size of 0.5 mm.
[0109] (2) Mix the sieved sodium sulfate, magnesium sulfate, potassium chloride and polyethylene glycol for 5 minutes to obtain a mixture I.
[0110] (3) Mixture I is continuously mixed with sodium lauryl sulfate for 5 min to obtain mixture II, which is then tableted.
[0111] Comparative Example 2
[0112] The compound sodium sulfate oral tablets, the prescription (dosage for 100 tablets) is as follows:
[0113] Sodium sulfate 147.9 g;
[0114] Magnesium sulfate 22.5g;
[0115] Potassium chloride 18.8g.
[0116] The preparation method thereof is specifically as follows:
[0117] (1) Sodium sulfate, magnesium sulfate and potassium chloride are sieved with a sieve mesh size of 1.5 mm.
[0118] (2) Mix the sieved sodium sulfate, magnesium sulfate and potassium chloride for 20 minutes to obtain a mixture I.
[0119] (3) Compress the mixture I into tablets.
[0120] Comparative Example 3
[0121] The compound sodium sulfate oral tablets, the prescription (dosage for 100 tablets) is as follows:
[0122] Chip:
[0123] Sodium sulfate 147.9 g;
[0124] Magnesium sulfate 22.5g;
[0125] Potassium chloride 18.8 g;
[0126] Polyethylene glycol 7g;
[0127] The coating layer includes the following components:
[0128] 4g of polyethylene glycol polyvinyl alcohol graft copolymer;
[0129] Polyethylene glycol 2g.
[0130] The preparation method thereof is specifically as follows:
[0131] (1) Sodium sulfate, magnesium sulfate and potassium chloride are sieved, and the sieve mesh size is 1.5 mm.
[0132] (2) Mix the sieved sodium sulfate, magnesium sulfate, potassium chloride and polyethylene glycol for 25 minutes to obtain mixture I.
[0133] (3) Compressing the mixture I into tablets and coating the tablets to obtain compound sodium sulfate tablets.
[0134] Comparative Example 4
[0135] The compound sodium sulfate oral tablets, the prescription (dosage for 100 tablets) is as follows:
[0136] Chip:
[0137] Sodium sulfate 147.9 g;
[0138] Magnesium sulfate 22.5g;
[0139] Potassium chloride 18.8 g;
[0140] Polyethylene glycol 13.5 g;
[0141] Sodium dodecyl sulfate 1.5g.
[0142] The coating layer includes the following components:
[0143] 4g of polyethylene glycol polyvinyl alcohol graft copolymer;
[0144] Polyethylene glycol 2g.
[0145] The preparation method thereof is specifically as follows:
[0146] (1) Sodium sulfate, magnesium sulfate and potassium chloride are sieved, and the sieve mesh size is 1.5 mm.
[0147] (2) Mix the sieved sodium sulfate, magnesium sulfate, potassium chloride and polyethylene glycol for 25 minutes to obtain mixture I.
[0148] (3) Mix mixture I and sodium dodecyl sulfate for 5 minutes to obtain mixture II.
[0149] (4) Compressing the mixture II into tablets and coating the tablets to obtain compound sodium sulfate tablets.
[0150] Comparative Example 5
[0151] The compound sodium sulfate tablets prepared in Example 1 using the original patent US11033498B2 prescription process are used as comparison column 5.
[0152] The preparations prepared in the above examples and comparative examples were tested for quality attributes, where the angle of repose was determined by: particles naturally fell from a funnel with a height of 8 cm onto a horizontal plate until no more particles fell from the funnel, and the angle θ between the formed cone and the horizontal plate was calculated. The powder fell freely from the funnel onto a disk to form a pile with a radius of r, and the height of the pile was fixed at h, then tanθ = h / r, and the results are shown in Table 1.
[0153] Table 1 Quality attribute test results
[0154]
[0155]
[0156] The taste of the tablets prepared by the examples and comparative examples is poor, and the uncoated tablets of comparative examples 1 and 2 have poor taste and are difficult to accept orally. The compound sodium sulfate tablets in the present invention, in which the mass ratio of polyethylene glycol to sodium lauryl sulfate is 3.5:1, have good taste and excellent quality.
[0157] The compound sodium sulfate oral tablets prepared in the above examples were subjected to an accelerated test (40°C ± 2°C, RH 75% ± 5%) according to the Chinese Pharmacopoeia Stability Test Guidelines. The results are shown in Table 2.
[0158] Table 2 Stability test results of compound sodium sulfate oral tablets prepared in Example
[0159]
[0160]
[0161] As can be seen from the above table, the compound sodium sulfate tablets prepared in Examples 1 to 4 of the present invention have excellent stability in the accelerated test (40°C ± 2°C, RH 75% ± 5%) for 6 months, and there is no significant change in various indicators compared with day 0. Comparative Examples 3 and 5 have extended disintegration times.
[0162] The above embodiments are preferred implementation modes of the present invention, but the implementation modes of the present invention are not limited to the above embodiments. Any other changes, modifications, substitutions, combinations, and simplifications that do not deviate from the spirit and principles of the present invention should be equivalent replacement methods and are included in the protection scope of the present invention.
Claims
1. A compound sodium sulfate tablet, characterized in that: It consists of a tablet core and a coating layer; the tablet core includes the following components: sodium sulfate, magnesium sulfate, potassium chloride, polyethylene glycol and sodium lauryl sulfate; The mass ratio of polyethylene glycol and sodium dodecyl sulfate to the mass ratio of the tablet core is 4.5% to 10.7%; The mass ratio of polyethylene glycol to sodium dodecyl sulfate is 3.5:
1.
2. The compound sodium sulfate tablet according to claim 1, characterized in that: The coating layer is one or more of hydroxypropyl methylcellulose, hydroxypropyl cellulose, povidone, polyvinyl alcohol, acrylic resin, polyvinyl acetal diethylamino acetate, propylene glycol, glycerol, polyethylene glycol, and polyethylene glycol polyvinyl alcohol graft copolymer.
3. The compound sodium sulfate tablet according to claim 1, characterized in that: The mass content of the coating layer is 2%~5% of the compound sodium sulfate tablets.
4. A method for preparing the compound sodium sulfate tablet according to any one of claims 1 to 3, characterized in that: The following steps are involved: (1) Screening sodium sulfate, magnesium sulfate and potassium chloride; (2) mixing the sieved sodium sulfate, magnesium sulfate, potassium chloride and polyethylene glycol to obtain mixture I; (3) mixing mixture I with sodium lauryl sulfate to obtain mixture II; (4) Compressing the mixture II into tablets and coating the tablets to obtain compound sodium sulfate tablets.
5. The method for preparing the compound sodium sulfate tablet according to claim 4, characterized in that: The aperture of the sieve used in step (1) is 0.5 mm to 2.5 mm.
6. The method for preparing the compound sodium sulfate tablet according to claim 4, characterized in that: The mixing time of step (2) is 5 min to 40 min; the mixing time of step (3) is 5 min to 20 min.
Citation Information
Patent Citations
Pharmaceutical composition with compound of sodium sulfate, potassium sulfate and magnesium sulfate as well as preparation method and application of pharmaceutical composition
CN104257686A
Sodium sulfate, potassium sulfate and magnesium sulfate oral solution and preparation method thereof
CN110339158A
Solid oral sulfate salt formulations for cleaning a colon and methods of using same
US11033498B2
